Novel 660 300 mg Pill - purple capsule/oblong, 14mm
Pill with imprint Novel 660 300 mg is Purple, Capsule/Oblong and has been identified as Trimethobenzamide Hydrochloride 300 mg. It is supplied by Gavis Pharmaceuticals.
Trimethobenzamide is used in the treatment of Nausea/Vomiting and belongs to the drug class anticholinergic antiemetics. FDA has not classified the drug for risk during pregnancy. Trimethobenzamide 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Novel 660 300 mg
Trimethobenzamide Hydrochloride
- Imprint
- Novel 660 300 mg
- Strength
- 300 mg
- Color
- Purple
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Anticholinergic antiemetics
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gavis Pharmaceuticals
- National Drug Code (NDC)
- 43386-0660
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
corn starch,
D&C Red No. 28,
gelatin,
FD&C Blue No. 1,
FD&C Red No. 40,
titanium dioxide,
soya lecithin,
water,
shellac,
ethylene glycol monoethyl ether
Note: Inactive ingredients may vary.
See also:
More about trimethobenzamide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (14)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: anticholinergic antiemetics
- Breastfeeding
- En español
Patient resources
- Trimethobenzamide oral/injection drug information
- Trimethobenzamide (Intramuscular) (Advanced Reading)
- Trimethobenzamide (Oral) (Advanced Reading)
- Trimethobenzamide Capsules
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.